Close
Register Sign In

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights, Dec. 2, 2020

Below are newsworthy items compiled by the Healthday staff: CDC To Shorten Recommended Quarantine Period The number of days that close contacts should...

Metabolites' From Food Could Affect Your Stroke Risk

WEDNESDAY, Dec. 2, 2020 -- Levels of some small molecules called metabolites in the body may affect your risk of stroke, a new analysis suggests. Metabolites...

Female Doctors Less Likely to Be Promoted to Upper Faculty Ranks

WEDNESDAY, Dec. 2, 2020 -- Women physicians in academic medical centers are less likely than men to be promoted to upper faculty ranks, according to a study...

AMA Pushes for Widespread Telehealth Adoption

WEDNESDAY, Dec. 2, 2020 -- At a Special Meeting of the AMA House of Delegates, the American Medical Association (AMA) adopted a new policy to advocate for...

Circulating Metabolites Linked to Risk for Incident Stroke

WEDNESDAY, Dec. 2, 2020 -- Circulating metabolites, including amino acids, glycolysis-related metabolites, acute phase reaction markers, and lipoprotein...

Boosting Coverage of Midwife Care Could Avert Deaths

WEDNESDAY, Dec. 2, 2020 -- About two-thirds of maternal deaths, neonatal deaths, and stillbirths could be averted with universal coverage of midwife-delivered...

CDC Shrinks COVID-19 Quarantine Time, Advises Against Holiday Travel

WEDNESDAY, Dec. 2, 2020 -- The U.S. Centers for Disease Control and Prevention has shortened the recommended length of quarantine after exposure to the new...

CDC Shrinks COVID Quarantine Time, Advises Against Holiday Travel

WEDNESDAY, Dec. 2, 2020 -- The U.S. Centers for Disease Control and Prevention delivered some good news and some bad news on Wednesday: The recommended length...

Relief for America's Unemployed Could Be Crucial for Health

WEDNESDAY, Dec. 2, 2020 -- Americans who lost their jobs this year due to the coronavirus pandemic have remained healthier and more secure thanks to...

Many Hospitalized COVID Patients Will Need Longer-Term Care at Home

WEDNESDAY, Dec. 2, 2020 -- When COVID-19 patients go home from the hospital, their recovery is often far from over -- and many might benefit from home health...

FDA Approves Imcivree (setmelanotide) for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

BOSTON, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing...

FDA Approves Danyelza (naxitamab-gqgk) for the Treatment of Neuroblastoma

NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage...

Liquidia Receives Complete Response Letter from FDA for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension

RESEARCH TRIANGLE PARK, N.C., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc., a wholly owned subsidiary of Liquidia Corporation (NASDAQ: LQDA),...

FDA Approves Oxlumo (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 24, 2020-- Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, announced today that the...

Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person

South San Francisco, CA -- November 23, 2020 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and...

FDA Approves Zokinvy (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies

PALO ALTO, Calif., Nov. 20, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted...

CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed

Berkeley Heights, NJ – November 18, 2020 – CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and...

Alkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records Review

DUBLIN, Nov. 17, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug...

Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH

WALTHAM, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals,?Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 t...

Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding Zimhi

SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that after the close of...

Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors

NEW YORK--(BUSINESS WIRE) November 23, 2020 -- Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 BASIS study of...

Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19

NEW YORK & MAINZ, Germany--(BUSINESS WIRE) December 02, 2020 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines...

Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066

HOUSTON, Dec. 1, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad...

Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 30, 2020-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and...

Novavax Announces COVID-19 Vaccine Clinical Development Progress

GAITHERSBURG, Md., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for...

Older Articles by News Type

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

246免费·天下彩